Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Masahiro Tanemura"'
Autor:
Masahiro Tanemura, Yoshifumi Iwagami, Hirofumi Akita, Kunihito Gotoh, Yoshito Tomimaru, Yuichiro Doki, Tadafumi Asaoka, Daisaku Yamada, Yoshihiro Sakano, Hidetoshi Eguchi, Takehiro Noda, Shogo Kobayashi, Koji Umeshita, Akihiro Kitagawa, Koshi Mimori
Publikováno v:
Digestive diseases and sciences. 67(8)
Combined hepatocellular and cholangiocarcinoma is a rare primary liver cancer with histological features of both hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Little is known about the prognostic features and molecular mechanism of cH
Autor:
Takashi Onoe, Tatsuya Miyamoto, Takeshi Sudo, Toshimitsu Irei, Megumi Yamaguchi, Masashi Inoue, Takao Hinoi, Takahisa Suzuki, Masahiro Tanemura, Shingo Seo, Yosuke Shimizu, Hirotaka Tashiro, Tomio Yuba, Toshihiro Misumi, Wataru Shimizu
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 7, Iss 10, Pp 1863-1869 (2019)
Clinical Case Reports, Vol 7, Iss 10, Pp 1863-1869 (2019)
Hepatic pseudolymphoma is a very rare benign reactive lymphoid hyperplasia associated with autoimmunity and chronic inflammatory liver diseases such as primary biliary cirrhosis and may mimic hepatocellular carcinoma. This diagnosis should be suspect
Autor:
Hiroshi Wada, Takehiro Noda, Hidetoshi Eguchi, Yutaka Takeda, Tadafumi Asaoka, Kunihito Gotoh, Yoshifumi Iwagami, Koji Umeshita, Daisaku Yamada, Koichi Kawamoto, Masahiro Tanemura, Masaki Mori, Yuichiro Doki
Publikováno v:
Surgical endoscopy. 32(1)
Repeat liver resection is an effective treatment, with long-term surgical outcomes for recurrent hepatocellular carcinoma and colorectal liver metastasis. However, the efficacy of a minimally invasive surgical approach for recurrent liver cancer is n
Autor:
Yukinobu Yoshikawa, Toshimitsu Irei, Yuichi Hiyama, Hiroshi Kohno, Hirotaka Kouno, Masashi Inoue, Masahiro Tanemura, Kiyomi Taniyama, Wataru Kamiike, Kazuya Kuraoka
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 47:18-25
Autor:
Yuichiro Doki, Yoshito Tomimaru, Masahiro Tanemura, Hiroshi Wada, Koji Umeshita, Hiroaki Nagano, Shigeru Marubashi, Masaki Mori, Hidetoshi Eguchi, Shogo Kobayashi
Publikováno v:
Experimental and Therapeutic Medicine
The efficacy of combination therapy with subcutaneous interferon (IFN)-α and intra-arterial 5-fluorouracil (5-FU) as a postoperative adjuvant for resectable advanced hepatocellular carcinoma (HCC) invading the major branches of the portal vein (PVTT
Autor:
Koji Umeshita, Hidetoshi Eguchi, Masahiro Tanemura, Hiroshi Wada, Shigeru Marubashi, Masaki Mori, Hiroaki Nagano, Shogo Kobayashi, Yuichiro Doki, Koichi Kawamoto
Publikováno v:
Surgical Endoscopy. 27:610-617
This study was designed to evaluate the surgical parameters and treatment outcomes of tumor hemodynamics-based pure laparoscopic (PURE) and laparoscopy-assisted (HYBRID) hepatectomy for small hepatocellular carcinoma (HCC) compared with those of open
Autor:
Hiroshi Wada, Yoshito Tomimaru, Shogo Kobayashi, Shigeru Marubashi, Masahiro Tanemura, Hiroaki Nagano, Koji Umeshita, Masaki Mori, Yuichiro Doki, Hidetoshi Eguchi
Publikováno v:
Digestive Diseases and Sciences. 57:1942-1948
Although anatomical resection (AR) is considered better than non-anatomical resection (NAR) for the treatment for hepatocellular carcinoma (HCC), there is only limited evidence in support of this argument.The aim of this study was to investigate whet
Autor:
Akira Tomokuni, Yoshito Tomimaru, Koji Umeshita, Hiroshi Wada, Hiroaki Nagano, Tatsuya Kanto, Shogo Kobayashi, Shigeru Marubashi, Masahiro Tanemura, Yuichiro Doki, Ichiro Takemasa, Hidetoshi Eguchi, Masaki Mori
Publikováno v:
Journal of Hepatology. 56:167-175
Background & Aims Several groups have reported the significance of circulating microRNA as a biochemical marker of cancer. To our knowledge, however, there are no reports on the significance of circulating microRNA in hepatocellular carcinoma. The ai
Autor:
Hiroshi Wada, Masahiro Tanemura, Shigeru Marubashi, Mamoru Uemura, Yuichiro Doki, Takehiro Noda, Masaki Mori, Hidetoshi Eguchi, Yoshito Tomimaru, Hirofumi Yamamoto, Shogo Kobayashi, Daisaku Yamada, Hiroaki Nagano
Publikováno v:
Annals of Surgical Oncology. 19:355-364
Intratumoral hypoxia affects every major aspect of cancer biology, but the relationship between hypoxia-induced genes and hepatocellular carcinoma has not been fully investigated. From a previously ranked microarray of hypoxia-inducible genes related
Autor:
Koji Umeshita, Hiroshi Wada, Masahiro Murakami, Yoshito Tomimaru, Shogo Kobayashi, Masahiro Tanemura, Hidetoshi Eguchi, Hiroaki Nagano, Yutaka Takeda, Takehiro Noda, Masaki Mori, Yuichiro Doki, Shigeru Marubashi
Publikováno v:
Annals of Surgical Oncology. 18:589-596
There is no standardized treatment for hepatocellular carcinoma (HCC) with portal vein tumor thrombus. We previously reported the efficacy of interferon-alpha and 5-fluorouracil combination (IFN/5-FU) therapy for these patients and the potential mech